- Home
- AVTX vs PHK Comparison
AVTX vs PHK Comparison
Compare AVTX & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVTX | PHK |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 776.8M |
| IPO Year | 2015 | 2003 |
Fundamental Metrics
Financial Performance| Metric | AVTX | PHK |
|---|---|---|
| Price | $7.81 | $4.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $34.80 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 976.8K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $6.53 | $4.01 |
| 52 Week High | $24.27 | $5.00 |
Technical Indicators
Market Signals| Indicator | AVTX | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 38.51 | 39.01 |
| Support Level | $6.53 | N/A |
| Resistance Level | $20.54 | $4.22 |
| Average True Range (ATR) | 0.62 | 0.07 |
| MACD | 0.36 | -0.00 |
| Stochastic Oscillator | 62.35 | 18.08 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its portfolio management approach combines top-down macroeconomic analysis with fundamental credit research to identify attractive investment opportunities. The fund seeks to generate consistent income while actively managing interest rate, credit, and market risks.